Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Raydel is a global healthcare company specializing in the development and distribution of evidence-based nutraceuticals, most notably its proprietary Policosanol. Originally founded as Rainbow and Nature, the company focuses on cardiovascular health, particularly cholesterol management and blood pressure regulation. Its flagship product, Raydel Policosanol, is derived from Cuban sugar cane wax and has undergone extensive clinical research to validate its efficacy in improving lipid profiles. Raydel operates primarily in Australia and South Korea, maintaining a strong emphasis on high-quality manufacturing and scientific validation of its natural health products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Raydel-policosanol.